MARKET

CAPR

CAPR

Capricor Therapeutics Inc
NASDAQ
31.52
-0.38
-1.19%
After Hours: 31.95 +0.43 +1.36% 19:15 05/12 EDT
OPEN
31.58
PREV CLOSE
31.90
HIGH
32.10
LOW
30.93
VOLUME
1.06M
TURNOVER
--
52 WEEK HIGH
40.37
52 WEEK LOW
4.300
MARKET CAP
1.82B
P/E (TTM)
-13.9463
1D
5D
1M
3M
1Y
5Y
1D
Capricor Therapeutics Q1 2026 Earnings Call Transcript
Benzinga · 1h ago
BRIEF-Capricor Therapeutics Reports First Quarter 2026 Financial Results
Reuters · 2h ago
FDA Commissioner Marty Makary resigns
TipRanks · 2h ago
Capricor Therapeutics Q1 net loss widens as expenses rise
Reuters · 2h ago
*Capricor Therapeutics: Runway Through 4Q27 >CAPR
Dow Jones · 2h ago
*Capricor Therapeutics 1Q Rev $0.00 >CAPR
Dow Jones · 2h ago
Capricor Therapeutics, Inc. GAAP EPS of -$0.59 misses by $0.06
Seeking Alpha · 3h ago
Capricor Q1 FY26 net loss widens to $33.9 million; revenue remains no revenue
PUBT · 3h ago
More
About CAPR
Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program is focused on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate deramiocel (also referred to as CAP-1002), is an allogeneic cardiac-derived cell therapy. CAP-1002 is advancing through Phase III clinical development for the treatment of Duchenne muscular dystrophy (DMD). CAP-1002 demonstrates immunomodulatory, antifibrotic, and regenerative actions specifically tailored for dystrophinopathies and heart disease. It leverages its exosome technology, using its StealthX platform in preclinical development focused on the areas of vaccinology, targeted delivery of oligonucleotides, proteins, and small molecule therapeutics.

Webull offers Capricor Therapeutics Inc stock information, including NASDAQ: CAPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAPR stock methods without spending real money on the virtual paper trading platform.